UFPTUFP Technologies, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though at the top of its own P/E range.
Expensive vs its own history: P/E 31.1 vs a 23.5 median over 41 quarters (+33% vs median).
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What UFPT's price assumes
UFP Technologies, Inc. trades at 31.1× earnings against 26.2× for the median Medical Devices name, more expensive than its own group.
Trailing P/E · Medical Devices median 26.2 · 1.19× the median: the market pays up for this one
- Price / sales
- 3.10
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 4.23
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 3.27
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 4.23
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 21.4
- EV / salestoday's price, trailing year to Jun 30, 2026
- 3.27
- Healthcare median P/E509 names
- 26.2
- Medical Devices median P/E64 names
- 26.2
- Market capitalisation
- $1.96B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $197.53 |
| Its own P/E history, median | $217.63 |
| Its own P/E history, upper quartile | $262.55 |
| 52-week range | $185.28 – $333.88 |
| Today | $288.80 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.